Naloxone does not antagonize PCP-induced stimulation of the pituitary-adrenal axis in the rat.

[1]  M. Carroll.  A quantitative assessment of phencyclidine dependence produced by oral self-administration in rhesus monkeys. , 1987, The Journal of pharmacology and experimental therapeutics.

[2]  W. D. Wessinger.  Behavioral dependence on phencyclidine in rats. , 1987, Life sciences.

[3]  T. Kameyama,et al.  Development of tolerance and supersensitivity to phencyclidine in rats after repeated administration of phencyclidine. , 1987, European journal of pharmacology.

[4]  T. Takao,et al.  Effects of (D-ala2, met5)-enkephalinamide and naloxone on ACTH and corticosterone secretion. , 1986, Endocrinologia japonica.

[5]  H. Kim,et al.  Effects of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes. , 1986, Life sciences.

[6]  T. O'donohue,et al.  Stereotyped behavior correlates better than ataxia with phencyclidine-receptor interactions. , 1986, European journal of pharmacology.

[7]  R. Poland,et al.  The effects of the acute administration of phencyclidine hydrochloride (PCP) on the release of corticosterone, growth hormone and prolactin in the rat. , 1986, Life sciences.

[8]  T. Kameyama,et al.  Involvement of opioid receptors in hypo- and hyperthermic effects induced by phencyclidine in mice. , 1986, Journal of pharmacobio-dynamics.

[9]  D. Jezova.  Stimulation of ACTH release by naloxone: central or peripheral action? , 1985, Life sciences.

[10]  J. W. Spain,et al.  Continuous intravenous infusion of phencyclidine in unrestrained rats results in the rapid induction of tolerance and physical dependence. , 1985, The Journal of pharmacology and experimental therapeutics.

[11]  N. Benowitz,et al.  Altered methadone pharmacokinetics in methadone-maintained pregnant women. , 1985, The Journal of pharmacology and experimental therapeutics.

[12]  R. Poland,et al.  Identification of multiple opiate receptors through neuroendocrine responses. II. Antagonism of mu, kappa and sigma agonists by naloxone and WIN 44,441-3. , 1985, The Journal of pharmacology and experimental therapeutics.

[13]  T. Nabeshima,et al.  Attenuation of pharmacological effects and increased metabolism of phencyclidine in morphine tolerant mice. , 1984, European journal of pharmacology.

[14]  M. Leid,et al.  Interaction of dextrorotatory opioids with phencyclidine recognition sites in rat brain membranes. , 1984, Life sciences.

[15]  A. Tomie,et al.  Effects of SKF-10047 in the phencyclidine-dependent rat: evidence for common receptor mechanisms. , 1983, Drug and alcohol dependence.

[16]  D. B. Vaupel,et al.  Naltrexone fails to antagonize the σ effects of PCP and SKF 10,047 in the dog , 1983 .

[17]  R. Zukin,et al.  Specific Binding of [3H] phencyclidine in rat central nervous tissue: further characterization and technical considerations , 1983, Brain Research.

[18]  S. Feldman,et al.  Effects of naloxone on basal and stress-induced ACTH and corticosterone secretion in the male rat - site and mechanism of action , 1982, Brain Research.

[19]  S. D. Glick,et al.  Naloxone antagonism of the thermoregulatory effects of phencyclidine. , 1982, Science.

[20]  H. Shannon.  Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats. , 1982, The Journal of pharmacology and experimental therapeutics.

[21]  J. Woods,et al.  Stereospecific binding of 3H-phencyclidine in brain membranes. , 1982, Life sciences.

[22]  R. Zukin,et al.  EFFECTS OF PHENCYCLIDINE AND ITS DERIVATIVES ON ENTERIC NEURONES , 1982, British journal of pharmacology.

[23]  R. Palmour,et al.  Naloxone and phencyclidine: Interacting effects on the limbic system and behavior , 1981, Physiology & Behavior.

[24]  Y. Sarne,et al.  On the opioid nature of phencyclidine and its 3-hydroxy derivative. , 1981, European journal of pharmacology.

[25]  S. Cohen,et al.  Receptor binding and antinociceptive properties of phencyclidine opiate-like derivatives. , 1981, European journal of pharmacology.

[26]  R. Rawson,et al.  Withdrawal from chronic phencyclidine (PCP) dependence with desipramine. , 1981, The American journal of psychiatry.

[27]  R. Rubin,et al.  Neonatal dexamethasone administration. I. Temporary delay of development of the circadian serum corticosterone rhythm in rats. , 1981, Endocrinology.

[28]  M. Fauman,et al.  Chronic phencyclidine (PCP) abuse: a psychiatric perspective. , 1980, Journal of psychedelic drugs.

[29]  R. Eisenberg.  Effects of naloxone on plasma corticosterone in the opiate-naive rat. , 1980, Life sciences.

[30]  P. Pyati,et al.  Inhibition of drug metabolism by chronically administered naltrexone. , 1979, Life sciences.

[31]  M. Lazdunski,et al.  Interaction of phencyclidines with the muscarinic and opiate receptors in the central nervous system , 1978, Brain Research.

[32]  T. F. Murray.  The effects of phencyclidine on operant behavior in the rat: biphasic effect and tolerance development. , 1978, Life sciences.

[33]  F. Bloom,et al.  beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. , 1977, Science.